Comprehensive information on 10,000+ stocks and funds, including all the companies in the S&P 500 index. See stock prices, news, social sentiment, financials, forecasts, business, management and more.
U.S. equities are hovering near record highs as the earnings season progresses, with roughly 60% of S&P 500 companies having reported and aggregate profits coming in ahead of expectations; this is helping justify elevated valuations after the market’s run-up into early August 2026.
Oil prices, which spiked around the late‑July Fed meeting, have stabilized on talk of progress toward securing shipping lanes in the Strait of Hormuz, easing one of the key macro pressures that had recently weighed on risk assets.
Investors remain focused on the Federal Reserve’s next steps after its July meeting left rates unchanged but kept the door open to a possible hike in September, with futures pricing roughly even odds and Treasury yields holding near their highest levels since early 2025.
Within earnings, several large industrial and tech names have reported upside surprises on both revenue and margins, supporting cyclical and AI‑linked shares and reinforcing the narrative that corporate America is managing higher rates and input costs better than feared.
At the same time, there are growing worries in parts of the market about stretched valuations, particularly in high‑flying technology and AI beneficiaries, leading to more volatile single‑stock reactions around earnings even when headline numbers beat estimates.
| Date | Ticker | Company Name | Offer Amount |
|---|---|---|---|
| Aug 4 | THEOU | BOA Acquisition Corp. II | $125,000,000 |
| Aug 4 | FJDIU | ARC Group Securities Acquisition I | $105,000,000 |
| Jul 31 | APMD | Apnimed, Inc. | $192,000,000 |
| Jul 31 | EWAVU | East West Ave Acquisition Corp. | $100,000,000 |
| Jul 31 | XIIIU | Churchill Capital Corp XIII | $360,000,000 |
| Date | Ticker | Company Name | Offer Amount |
|---|---|---|---|
| Aug 5 | TCGX | TCGX Acquisition Corp. | $75,000,000 |
| Aug 5 | ATTO | Attovia Therapeutics, Inc. | $289,000,000 |
| Aug 6 | BRVE | Braveheart Bio, Inc. | $366,562,500 |
| Aug 6 | OCLTU | OceanLight Acquisition Corp | $115,000,000.00 |
| Aug 6 | PHAXU | Phalanx Acquisition Corp I | $201,250,000 |